GI Biome, an affiliate of GI Innovation, announced on the 21st that it has entered into an MOU with Inhandplus, an artificial intelligence (AI) smartwatch-based medication management solution provider, and GII Vita, a digital healthcare service platform company. The collaboration aims to develop and expand into the global market for Decentralized Clinical Trials (DCT).

Under this agreement, the three companies plan to introduce a medication monitoring system through smart devices and personalized medication management services into clinical trials. Through this initiative, they aim to propel the development of an optimized DCT platform and global business expansion.

Read more: https://n.news.naver.com/mnews/article/277/0005275434?sid=101